To further explore the relationship between PELP1 and TFAP2C in BC and in therapy resistance, we established in vitro BC models (MCF7 and ZR75) that overexpress TFAP2C and that underexpress PELP1 (Fig. 3A). This evidence concerns the gene PELP1 and breast cancer.